相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An injectable nanoparticle generator enhances delivery of cancer therapeutics
Rong Xu et al.
NATURE BIOTECHNOLOGY (2016)
Predicting the Response of Breast Cancer to Neoadjuvant Therapy Using a Mechanically Coupled Reaction-Diffusion Model
Jared A. Weis et al.
CANCER RESEARCH (2015)
Improving Cancer Treatment via Mathematical Modeling: Surmounting the Challenges Is Worth the Effort
Franziska Michor et al.
CELL (2015)
Integrated PK-PD and agent-based modeling in oncology
Zhihui Wang et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2015)
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
Berna C. Oezdemir et al.
CANCER CELL (2014)
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Andrew D. Rhim et al.
CANCER CELL (2014)
Mathematical modeling in cancer drug discovery
Zhihui Wang et al.
DRUG DISCOVERY TODAY (2014)
Transport properties of pancreatic cancer describe gemcitabine delivery and response
Eugene J. Koay et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Intratumor heterogeneity alters most effective drugs in designed combinations
Boyang Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer
Eugene J. Koay et al.
PHYSICAL BIOLOGY (2014)
Mechanistic Modeling Identifies Drug-Uptake History as Predictor of Tumor Drug Resistance and Nano-Carrier-Mediated Response
Jennifer Pascal et al.
ACS NANO (2013)
Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
Yuhui Huang et al.
CANCER RESEARCH (2013)
Benefits of Vascular Normalization Are Dose and Time Dependent-Letter
Yuhui Huang et al.
CANCER RESEARCH (2013)
Enhancing Chemotherapy Response with Sustained EphA2 Silencing Using Multistage Vector Delivery
Haifa Shen et al.
CLINICAL CANCER RESEARCH (2013)
Use of Molecular Biomarkers to Quantify the Spatial Distribution of Effects of Anticancer Drugs in Solid Tumors
Jasdeep K. Saggar et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Influence of tumour micro-environment heterogeneity on therapeutic response
Melissa R. Junttila et al.
NATURE (2013)
A mechanically coupled reaction-diffusion model for predicting the response of breast tumors to neoadjuvant chemotherapy
Jared A. Weis et al.
PHYSICS IN MEDICINE AND BIOLOGY (2013)
A Computational Model for Predicting Nanoparticle Accumulation in Tumor Vasculature
Hermann B. Frieboes et al.
PLOS ONE (2013)
Impact of Diffusion Barriers to Small Cytotoxic Molecules on the Efficacy of Immunotherapy in Breast Cancer
Hiranmoy Das et al.
PLOS ONE (2013)
A Mathematical Model of the Enhanced Permeability and Retention Effect for Liposome Transport in Solid Tumors
Shawn Stapleton et al.
PLOS ONE (2013)
Mechanistic patient-specific predictive correlation of tumor drug response with microenvironment and perfusion measurements
Jennifer Pascal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Multistage Vectored siRNA Targeting Ataxia-Telangiectasia Mutated for Breast Cancer Therapy
Rong Xu et al.
SMALL (2013)
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
Vikash P. Chauhan et al.
NATURE COMMUNICATIONS (2013)
Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo
Greg M. Thurber et al.
NATURE COMMUNICATIONS (2013)
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
Paolo P. Provenzano et al.
CANCER CELL (2012)
Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies
Hiroshi Haeno et al.
CELL (2012)
Integrated intravital microscopy and mathematical modeling to optimize nanotherapeutics delivery to tumors
Anne L. van de Ven et al.
AIP ADVANCES (2012)
Vascular Normalization as a Therapeutic Strategy for Malignant and Nonmalignant Disease
Shom Goel et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Multiscale Cancer Modeling
Thomas S. Deisboeck et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 13 (2011)
Plasma and cellular pharmacokinetics of doxorubicin after intravenous infusion of Caelyx™/Doxil® in patients with hematological tumors
H. Richly et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Duration of Chemotherapy for Metastatic Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Alessandra Gennari et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A novel, patient-specific mathematical pathology approach for assessment of surgical volume: Application to ductal carcinoma in situ of the breast
Mary E. Edgerton et al.
ANALYTICAL CELLULAR PATHOLOGY (2011)
Physiologically Based Pharmacokinetic Modeling of Nanoparticles
Mingguang Lu et al.
ACS NANO (2010)
Mechanistic modelling of dynamic MRI data predicts that tumour heterogeneity decreases therapeutic response
R. Venkatasubramanian et al.
BRITISH JOURNAL OF CANCER (2010)
Sustained Small Interfering RNA Delivery by Mesoporous Silicon Particles
Takemi Tanaka et al.
CANCER RESEARCH (2010)
Size and shape effects in the biodistribution of intravascularly injected particles
P. Decuzzi et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Tuning payload delivery in tumour cylindroids using gold nanoparticles
Byoungjin Kim et al.
NATURE NANOTECHNOLOGY (2010)
Metronomic chemotherapy: new rationale for new directions
Eddy Pasquier et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Frontiers in cancer nanomedicine: directing mass transport through biological barriers
Mauro Ferrari
TRENDS IN BIOTECHNOLOGY (2010)
The Role of Transforming Growth Factor-β-Mediated Tumor-Stroma Interactions in Prostate Cancer Progression: An Integrative Approach
David Basanta et al.
CANCER RESEARCH (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Drug resistance and the solid tumor microenvironment
Olivier Tredan et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Tetrandrine achieved plasma concentrations capable of reversing MDR in vitro and had no apparent effect on doxorubicin pharmacokinetics in mice
Chun-Ling Dai et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Effect of vascular normalization, by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: Insights from a mathematical model
Rakesh K. Jain et al.
CANCER RESEARCH (2007)
Drug penetration in solid tumours
Andrew I. Minchinton et al.
NATURE REVIEWS CANCER (2006)
A pegylated liposomal platform: Pharmacokinetics, pharmacodynamics, and toxicity in mice using doxorubicin as a model drug
WL Lu et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)
Tumor physiology and drug resistance
IF Tannock
CANCER AND METASTASIS REVIEWS (2001)
分享论文
